Management Committee Executive Group
Jim Keon
Chair, IGBA
President, Canadian Generic Pharmaceutical Association
President, Biosimilars Canada
Jim Keon is President of the Canadian Generic Pharmaceutical Association (CGPA), and President of Biosimilars Canada organizations representing Canada’s generic and biosimilar pharmaceutical sectors. Jim graduated with an M.A. in Economics from Queen’s University and has more than 30 years experience in the pharmaceutical sector. Jim has served as President of the CGPA since 1998 and was named the founding President of Biosimilars Canada in January 2015. Prior to joining CGPA in 1994 he held senior positions in the federal government and was directly involved in international trade negotiations for NAFTA and the WTO, as well as Canada’s inter-provincial trade negotiations. Jim is a past Chair and is currently Vice Chair (2025) of the Management Committee of the International Generic and Biosimilars Medicines Association (IGBA). The IGBA is committed to promoting the interests of generic and biosimilars medicines around the world.
Mariano Genovesi
Vice-Chair, IGBA
General Counsel and Intellectual Property Director
Argentine Pharmaceutical Industry Chamber (CILFA)
Mariano Genovesi is General Counsel and Intellectual Property Director at the Argentine Pharmaceutical Industry Chamber (CILFA), the association representing generic and biosimilar manufacturers in Argentina. He has more than 30 years of experience in the pharmaceutical industry, with a strong focus on intellectual property, competition law, and regulatory matters in Argentina and Latin America.
He is a member of the Board of Directors and President of the Parliamentary Relations Department of the Argentine Industrial Union (UIA), where he has represented the organization in MERCOSUR–European Union free trade agreement negotiations and in several Business 20 (B20) working groups.
Mr. Genovesi has extensive litigation experience, particularly in intellectual property and competition law. He has acted as lead counsel in landmark pharmaceutical cases involving data exclusivity, the Bolar exemption, damages for abusive injunctions, and the regulatory approval of biosimilars.
He previously served as Secretary General of the University of Buenos Aires (2018–2022) and has worked as a consultant for international organizations, including the Inter-American Development Bank (IDB), UNCTAD and WIPO, as well as for governmental bodies in Argentina and Peru, focusing on technology transfer, biotechnology protection, and the implementation of intellectual property provisions in trade agreements.
Mr. Genovesi is a full professor of Business Law at the University of Buenos Aires and teaches courses on industrial property, competition, and markets. He has published extensively in his field and serves as a peer reviewer for leading international journals on intellectual property and competition law.
Shinichiro Hirose
Immediate Past Chair, IGBA
Director of International Affairs, Japan Generic Medicines Association (JGA)
Shinichiro Hirose is the director of international affairs at the Japan Generic Medicines Association (JGA), a member association of the IGBA. In this position, he is responsible for coordinating activities on international affairs and other expert committees of the association. He is a member of IGBA management committee, and other standing committees. He is also engaged in ICH project, taking a role as ICH coordinator for IGBA. Before joining JGA, he worked for pharmaceutical industry over 30 years, and has experiences in research, business development, and marketing for international markets. He holds the Ph.D. degree in pharmaceutical sciences from the university of Tokyo, Japan.
